Analyzing uterine and cervical samples to detect ovarian cancer early

Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer

NIH-funded research Massachusetts General Hospital · NIH-10674873

This study is looking at how to use samples from the uterus and cervix to find early signs of ovarian cancer, helping women get diagnosed sooner and more easily through regular check-ups.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10674873 on NIH RePORTER

What this research studies

This research investigates the use of uterine lavage and cervical swab samples to identify early signs of ovarian cancer. By employing advanced genome-wide methylation and proteomic analysis techniques, the study aims to find biological signals that indicate the presence of ovarian cancer at an earlier stage than current methods allow. The approach focuses on optimizing a combined test that can detect these signals in samples collected from women, potentially leading to more effective early detection strategies. Patients may provide samples through routine gynecological procedures, making participation accessible.

Who could benefit from this research

Good fit: Ideal candidates for this research are postmenopausal women who are at normal risk for ovarian cancer and are undergoing routine gynecological examinations.

Not a fit: Patients who are not postmenopausal or those with a high risk of ovarian cancer due to genetic factors may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to a more reliable method for early detection of ovarian cancer, improving treatment outcomes.

How similar studies have performed: Previous research has shown promise in using alternative biospecimens for cancer detection, but this specific approach is novel and untested.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Antigen 125Cancersneoplasm/cancerEpithelial cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.